What to Do About Steroid-Dependent Dermatitis
Steroid-dependent dermatitis results from prolonged topical application of corticosteroid ointments or cosmetic products containing corticosteroids, leading to impairment of the facial skin barrier and thinning of the stratum corneum. Clinical manifestations include folliculitis-like lesions, telangiectasia, hyperpigmentation, and hirsutism. The disease course is recurrent and chronic.

Treatment of steroid-dependent dermatitis begins with complete discontinuation of topical corticosteroids. Concurrently, oral medications—including hydroxychloroquine, compound glycyrrhizin tablets, vitamin C, and antihistamines—may be prescribed to alleviate cutaneous hypersensitivity and reduce erythematous reactions. Additionally, non-steroidal topical calcineurin inhibitors—such as tacrolimus ointment or pimecrolimus cream—can be applied.

Patients should routinely use medical-grade skincare products with moisturizing and soothing properties. Such products are free of alcohol, fragrance, and preservatives, thereby facilitating skin barrier repair and permitting long-term use.